Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjunctive Treatment of Major Depressive Disorder”

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01155661
What this trial is testing

A Safety Study in Participants With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Eli Lilly and Company 608
Testing effectiveness (Phase 2)Looking for participantsNCT07226661
What this trial is testing

Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder (MDD)
Supernus Pharmaceuticals, Inc. 230
Large-scale testing (Phase 3)Looking for participantsNCT06786624
What this trial is testing

Study to Assess the Efficacy and Safety of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Neurocrine Biosciences 200
Testing effectiveness (Phase 2)Study completedNCT02153502
What this trial is testing

Efficacy, Safety, and Tolerability Study of AVP-786 as an Adjunctive Therapy in Patients With Major Depressive Disorder With an Inadequate Response to Antidepressant Treatment

Who this might be right for
Depressive Disorder, Treatment-Resistant
Otsuka Pharmaceutical Development & Commercialization, Inc. 206
Testing effectiveness (Phase 2)Study completedNCT03018340
What this trial is testing

Study to Evaluate the Efficacy and Safety of Adjunctive Pimavanserin in Major Depressive Disorder (CLARITY)

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
ACADIA Pharmaceuticals Inc. 207
Large-scale testing (Phase 3)Ended earlyNCT04000009
What this trial is testing

Extension Study of Pimavanserin in Subjects With Major Depressive Disorder and Inadequate Response to Antidepressant Treatment

Who this might be right for
Adjunctive Treatment of Major Depressive Disorder
ACADIA Pharmaceuticals Inc. 235
Early research (Phase 1)Not Yet RecruitingNCT07683988
What this trial is testing

Oral and Sublingual Ketamine

Who this might be right for
Major Depression Severe
Western University, Canada 10
Large-scale testing (Phase 3)Study completedNCT03738215
What this trial is testing

Efficacy, Safety and Tolerability of Cariprazine as an Adjunctive Treatment to Antidepressant Therapy (ADT) in Patients With Major Depressive Disorder (MDD) Who Have Had an Inadequate Response to Antidepressants Alone

Who this might be right for
Major Depressive Disorder
AbbVie 759
Large-scale testing (Phase 3)Study completedNCT01942785
What this trial is testing

Study of Brexpiprazole as Adjunctive Treatment of Irritability in Patients With Major Depressive Disorder and an Inadequate Response to Antidepressant Therapy

Who this might be right for
Major Depressive DisorderIrritability
H. Lundbeck A/S 55
Testing effectiveness (Phase 2)Study completedNCT01052077
What this trial is testing

Study of the Safety and Efficacy of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 773
Testing effectiveness (Phase 2)Study completedNCT04969510
What this trial is testing

A Clinical Trial of Adjunctive and Monotherapy PRAX-114 in Participants With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Praxis Precision Medicines 110
Large-scale testing (Phase 3)Looking for participantsNCT07412756
What this trial is testing

Brenipatide in Adult Participants With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Eli Lilly and Company 1,000
Large-scale testing (Phase 3)Study completedNCT02141399
What this trial is testing

A Long-Term Safety Study of ALKS 5461

Who this might be right for
Major Depressive Disorder
Alkermes, Inc. 1,485
Not applicableStudy completedNCT01971203
What this trial is testing

Efficacy of Extended-release Quetiapine (Seroquel XR) as Adjunctive Therapy to Cognitive Behavioral Therapy in the Treat

Who this might be right for
Major Depressive DisorderGeneralized Anxiety Disorder
Icahn School of Medicine at Mount Sinai 62
Testing effectiveness (Phase 2)Study completedNCT03227224
What this trial is testing

Evaluate the Efficacy and Safety of JNJ-42847922 as Adjunctive Therapy to Antidepressants in Adult Participants With Major Depressive Disorder Who Have Responded Inadequately to Antidepressant Therapy

Who this might be right for
Depressive Disorder, Major
Janssen Research & Development, LLC 287
Large-scale testing (Phase 3)WithdrawnNCT02212613
What this trial is testing

Brexpiprazole (OPC 34712) Trial in the Treatment of Adults With Major Depressive Disorder and Irritability

Who this might be right for
Major Depressive Disorder and Irritability
Otsuka Pharmaceutical Development & Commercialization, Inc.
Large-scale testing (Phase 3)Study completedNCT03002077
What this trial is testing

Long-term Safety Study of Rapastinel as Adjunctive Therapy in Patients With Major Depressive Disorder

Who this might be right for
Depressive Disorder, Major
Naurex, Inc, an affiliate of Allergan plc 617
Testing effectiveness (Phase 2)Study completedNCT00212797
What this trial is testing

Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)

Who this might be right for
DepressionDepressive DisordersPsychotic Disorders
Merck Sharp & Dohme LLC 273
Large-scale testing (Phase 3)Study completedNCT01185340
What this trial is testing

A Study in Participants With Major Depressive Disorder Who Are Partial Responders to Selective Serotonin Reuptake Inhibitor

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 1,056
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06168175
What this trial is testing

Feasibility of Conducting a Clinical Trial Assessing Efficacy of Lactate as Adjunctive Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Centre Hospitalier Universitaire Vaudois 46
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation